Similar to our finding that gemR cells have relatively high levels of CDC25B, upregulation of this protein by PI3K-Akt-mTOR inhibitors is associated with resistance to this family of inhibitors in AML[46]. Here, CDC25B is linked to acute myeloid leukemia.